Skip to content
  • What’s
    Your Focus
    • Develop Anti-Aging Interventions
    • Validate and Expand Health Claims
    • Target Age-Related Diseases
    • Study the Biology of Aging
    • Ensure the Safety of Your Products
    • I want to start working with NAMs
  • Products &
    Assays
    • Organism-on-Chip technology
    • SydLab™ One Platform
    • NAGI™ Biological Age
    • Consumables & Reagents
  • Contract
    Research Services
    • Aging and Longevity Studies
    • Neurodegenerative Studies
    • Toxicity Studies
    • Compound Efficacy Studies
    • Microbiome Studies
    • Custom Studies
  • Applications
    • Fundamental Research
      • Aging and age-related Diseases
      • Neurodegenerative Diseases
    • Candidate Discovery
      • Aging and age-related Diseases
      • Neurodegenerative Diseases
    • Safety Toxicology
      • Developmental and Reproductive Toxicity
  • Resources
    • Resource Center
    • Nagi Blog
  • About Nagi
    • Our story
    • News
    • Events
    • Careers
  • Contact us
  • LinkedIn
  • X
  • Unlocking New Frontiers in Longevity & Healthspan

    As aging research remains at the forefront of biomedical science and an increasingly growing social issue, understanding the biological mechanisms behind cellular and organismal decline is crucial to extending healthspan — the period of life spent in good health — and overall lifespan. Despite the need to accelerate the discovery of preventive aging interventions, traditional…

    January 24, 2025
  • Loss of Sirt1 function improves intestinal anti-bacterial defense and protects from colitis-induced colorectal cancer.

    Dysfunction of Paneth and goblet cells in the intestine contributes to inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC). Here, we report a role for the NAD+-dependent histone deacetylase SIRT1 in the control of anti-bacterial defense. Mice with an intestinal specific Sirt1 deficiency (Sirt1int-/-) have more Paneth and goblet cells with a consequent rearrangement…

    March 13, 2023
  • Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research.

    In recent years, tetracyclines, such as doxycycline, have become broadly used to control gene expression by virtue of the Tet-on/Tet-off systems. However, the wide range of direct effects of tetracycline use has not been fully appreciated. We show here that these antibiotics induce a mitonuclear protein imbalance through their effects on mitochondrial translation, an effect that likely…

    March 13, 2023
  • Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents.

    The biological effects of urolithins remain poorly characterized, despite wide-spread human exposure via the dietary consumption of their metabolic precursors, the ellagitannins, which are found in the pomegranate fruit, as well as in nuts and berries. We identified urolithin A (UA) as a first-in-class natural compound that induces mitophagy both in vitro and in vivo following…

    March 13, 2023
  • Tetracycline-induced mitohormesis mediates disease tolerance against influenza

    Mitohormesis defines the increase in fitness mediated by adaptive responses to mild mitochondrial stress. Tetracyclines inhibit not only bacterial but also mitochondrial translation, thus imposing a low level of mitochondrial stress on eukaryotic cells. We demonstrate in cell and germ-free mouse models that tetracyclines induce a mild adaptive mitochondrial stress response (MSR), involving both the…

    March 13, 2023
←Previous Page
1 2
    • LinkedIn
    • X

Contact

Nagi Bioscience SA
EPFL Innovation Park (M)
Rue des Jordils 1A
1025 Saint-Sulpice, Switzerland
Email: info@nagibio.ch

Links

  • Contract Laboratories Solutions
  • Applications
  • Industries
  • Resources
  • About Nagi
  • Contact Us

Legal

  • Change Cookie Settings
  • Terms and Conditions
  • Privacy Policy

© 2025 Nagi Bioscience • All rights reserved